Bio Medica Laboratories Limited Financial Ratios
BMLL · Healthcare · Current price ₹155
P/E ratio
12.0x
P/B ratio
2.7x
ROE
44.4%
ROCE
27.8%
Debt / Equity
1.51
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 12.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 44.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 27.8% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.51 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Bio Medica Laboratories Limited's latest numbers.
Bio Medica Laboratories Limited profitability
Bio Medica Laboratories Limited generates a return on equity of 44.4% and a return on capital employed of 27.8%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.51 and a P/E of 12.0x, Bio Medica Laboratories Limited is carrying meaningful debt. Our overall business-quality score for the company is 6.9 / 10.
Understand the ratios
More on Bio Medica Laboratories Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.